PolyPid

company

About

PolyPid offers a technology platform that enables a controlled and prolonged release of any active pharmaceutical ingredients (API).

  • 51 - 100

Details

Last Funding Type
Post-IPO Debt
Last Funding Money Raised
$15M
Industries
Biopharma,Biotechnology,Health Care,Pharmaceutical
Founded date
Jan 1, 2008
Number Of Employee
51 - 100
Operating Status
Active

PolyPid is a development stage company that has developed a platform technology for the healthcare industry that enables a controlled and prolonged release of any active pharmaceutical ingredients (API).

PolyPid’s technology combines polymers and lipids, enabling small-and-large API entrapment in degradation and hydration protected environments, regardless of their chemical or physical characteristics.

PolyPid allows the release of the API from the reservoir at pre-determined rates of up to several months, with a constant release rate (zero-order kinetics). The flexibility of this innovative technology enables local administration of compounds across numerous therapeutic classes for several applications.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$15M
PolyPid has raised a total of $15M in funding over 2 rounds. Their latest funding was raised on Apr 6, 2022 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 6, 2022 Post-IPO Debt $15M 1 Kreos Capital Detail

Investors

Number of Lead Investors
Number of Investors
1
1
PolyPid is funded by 1 investors. Kreos Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Kreos Capital Yes Post-IPO Debt